Analyses of the toxic properties of recombinant human Cyclophilin A in mice

References

• Abreu D, Monteiro J, Souza C, Karam R, Fernandes R, Lessa T, Fagliari J, Miglino M, Ambrosio C. 2018. Immunophenotyping lymphocyte and acute phase proteins in canine X-linked muscular dystrophy. An Acad Bras Ciênc. 90(3):2977–2990.
   PubMed Web of Science ®Google Scholar
• Arora K, Gwinn W, Bower M, Watson A, Okwumabua I, MacDonald H, Bukrinsky M, Constant S. 2005. Extracellular cyclophilins contribute to the regulation of inflammatory responses. J Immunol. 175(1):517–522.
   PubMed Web of Science ®Google Scholar
• Badolato R, Wang J, Murphy W, Lloyd A, Michiel D, Bausserman L, Kelvin D, Oppenheim J. 1994. Serum amyloid A is a chemoattractant: Induction of migration, adhesion, and tissue infiltration of monocytes and polymorphonuclear leukocytes. J Exp Med. 180(1):203–209.
   PubMed Web of Science ®Google Scholar
• Bikov V. 2002. Cytology and general histology. St. Petersburg: SOTIS.
   Google Scholar
• Ceron J, Pardo-Marin L, Caldin M, Furlanello T, Solano-Gallego L, Tecles F, Bernal L, Baneth G, Martinez-Subiela S. 2018. Use of acute phase proteins for the clinical assessment and management of canine leishmaniosis: General recommendations. BMC Vet Res. 14(1):196.
   PubMedGoogle Scholar
• Colgan J, Asmal M, Neagu M, Yu B, Schneidkraut J, Lee Y, Sokolskaja E, Andreotti A, Luban J. 2004. Cyclophilin A regulates TCR signal strength in CD4+ T-cells via a proline-directed conformational switch in Itk. Immunity. 21(2):189–201.
   PubMed Web of Science ®Google Scholar
• Cray C, Zaias J, Altman N. 2009. Acute phase response in animals: A review. Comp Med. 59(6):517–526.
   PubMed Web of Science ®Google Scholar
• Damsker JM, Bukrinsky MI, Constant SL. 2007. Preferential chemotaxis of activated human CD4+ T-cells by extracellular cyclophilin A. J Leukoc Biol. 82(3):613–618.
   PubMed Web of Science ®Google Scholar
• Dong Z, Wu T, Qin W, An C, Wang Z, Zhang M, Zhang Y, Zhang C, An F. 2011. Serum amyloid A directly accelerates progression of atherosclerosis in apolipoprotein Edeficient mice. Mol Med. 17:1357–1364.
   Google Scholar
• Festing M. 1979. Properties of inbred strains and outbred stocks with special reference to toxicity testing. J Toxicol Environ Health. 5(1):53–68.
   PubMed Web of Science ®Google Scholar
• Fischer G, Bang H, Mech C. 1984. Determination of enzymatic catalysis for cis-trans-isomerization of peptide binding in proline-containing peptides. Biomed Biochim Acta. 43(10):1101–1111.
   PubMedGoogle Scholar
• Fruman D, Burakoff S, Bierer B. 1994. Immunophilins in protein folding and immunosuppression. Faseb J. 8(6):391–400.
   PubMed Web of Science ®Google Scholar
• Guo M, James A, Kwak J, Shen J, Yokoyama K, Ting K, Soo C, Chiu R. 2016. Cyclophilin A (CypA) plays dual roles in regulation of bone anabolism and resorption. Sci Rep. 6:22378.
   PubMed Web of Science ®Google Scholar
• Hong F, Lee J, Piao Y, Jae Y, Kim Y, Oh C, Seo J, Yun Y, Yang C, Ha J, et al. 2004. Trans-genic mice over-expressing cyclophilin A are resistant to cyclosporin A-induced nephrotoxicity via peptidyl-prolyl cis-trans isomerase activity. Biochem Biophys Res Commun. 316(4):1073–1080.
   PubMed Web of Science ®Google Scholar
• Hong F, Lee J, Song J, Lee S, Ahn H, Cho J, Ha J, Kim S. 2002. Cyclosporin A blocks muscle differentiation by inducing oxidative stress and inhibiting the peptidyl-prolyl-cis-trans isomerase activity of cyclophilin A: Cyclophilin A protects myoblasts from cyclosporin A-induced cytotoxicity. Faseb J. 16(12):1633–1635.
   PubMedGoogle Scholar
• Huang C, Chang C, Kuo C, Huang C, Lin C, Liu C. 2015. Decrease in plasma cyclophilin A concentration at 1-mo after myocardial infarction predicts better left ventricular performance and synchronicity at 6 mo: A pilot study in patients with ST elevation myocardial infarction. Int J Biol Sci. 11(1):38–47.
   PubMed Web of Science ®Google Scholar
• Jin Z, Melaragno M, Liao D, Yan C, Haendeler J, Suh Y, Lambeth J, Berk B. 2000. Cyclophilin A is a secreted growth factor induced by oxidative stress. Circ Res. 87(9):789–796.
   PubMed Web of Science ®Google Scholar
• Khalighi M, Wallace W, Palma-Diaz M. 2014. Amyloid nephropathy. Clin Kidney J. 7(2):97–106.
   PubMedGoogle Scholar
• Khromykh L, Kulikova N, Anfalova T, Muranova T, Abramov V, Vasiliev A, Khlebnikov V, Kazansky D. 2007. Cyclophilin A produced by thymocytes regulates the migration of murine bone marrow cells. Cell Immunol. 249(1):46–53.
   PubMed Web of Science ®Google Scholar
• Khromykh L, Kalinina A, Kozir A, Kolesnikov A, Silaeva Y, Kazanskiy D. 2016. Escherichia coli BL21(DE3)GoldpETCYPoptistrain-producer of recombinant human Cyclophilin A. Moscow, Russia, Patent #603283.
   Google Scholar
• Lee H, Kim S, Shim J, Lee S, Lee H, Cho K, Yun J, Bae Y. 2008. Serum amyloid A induces CCL2 production via formyl peptide receptor-like 1-mediated signaling in human monocytes. J Immunol. 181(6):4332–4339.
   PubMed Web of Science ®Google Scholar
• Li Y, Yan J, Wu C, Wang Z, Yuan W, Wang D. 2014. CD137-CD137L interaction regulates atherosclerosis via cyclophilin A in apolipoprotein E-deficient mice. PLoS One. 9(2):e88563.
   PubMed Web of Science ®Google Scholar
• Liu X, Zhao Z, Xu C, Sun L, Chen J, Zhang L, Liu W. 2012. Cyclophilin A restricts influenza A virus replication through degradation of the M1 protein. PLoS One. 7(2):e31063.
   PubMed Web of Science ®Google Scholar
• Malyala P, Singh M. 2008. Endotoxin limits in formulations for preclinical research. J Pharm Sci. 97(6):2041–2044.
   PubMed Web of Science ®Google Scholar
• Mironov A. 2012. Guidelines for preclinical studies of drugs. Guidelines for the study of the general toxic effect of drugs. Griph K. 1:13–25.
   Google Scholar
• Mullan R, Bresnihan B, Golden-Mason L, Markham T, O'Hara R, Fitzgerald O, Veale D, Fearon U. 2006. Acute-phase serum amyloid A stimulation of angiogenesis, leukocyte recruitment, and matrix degradation in rheumatoid arthritis through an NF-#B-dependent signal trans-duction pathway. Arthritis Rheum. 54:105–114.
   Google Scholar
• Murata H, Shimada N, Yoshioka M. 2004. Current research on acute phase proteins in veterinary diagnosis: an overview. Vet J. 168(1):28–40.
   PubMed Web of Science ®Google Scholar
• Nigro P, Pompilio G, Capogrossi M. 2013. Cyclophilin A: a key player for human disease. Cell Death Dis. 4:e888.
   PubMed Web of Science ®Google Scholar
• Nigro P, Satoh K, O'Dell M, Soe N, Cui Z, Mohan A, Abe J, Alexis J, Sparks J, Berk B. 2011. Cyclophilin A is an inflammatory mediator that promotes atherosclerosis in apolipoprotein E-deficient mice. J Exp Med. 208(1):53–66.
   PubMed Web of Science ®Google Scholar
• Padmanabhan S, editor. 2014. Animal models in pharmacogenomics: Handbook of pharmacogenomics and stratified medicine. New York: Elsevier; p. 73–87, Chapter 5.
   Google Scholar
• Perrucci G, Straino S, Corliano M, Scopece A, Napolitano M, Berk B, Lombardi F, Pompilio G, Capogrossi M, Nigro P. 2016. Cyclophilin A modulates bone marrow-derived CD117+ cells and enhances ischemia-induced angiogenesis via the SDF-1/CXCR4 axis. Int J Cardiol. 212:324–335.
   PubMed Web of Science ®Google Scholar
• Prozorovskii V. 2007. Statistic processing of data of pharmacological investigations. Psycho-Pharmacol Biol Narcol. 7:2090–2120.
   Google Scholar
• Ramachandran S, Venugopal A, Kutty V, Chitrasree V, Mullassari A, Pratapchandran N, Santosh K, Pillai M, Kartha C. 2014. Plasma level of cyclophilin A is increased in patients with type 2 diabetes mellitus and suggests presence of vascular disease. Cardiovasc Diabetol.13:38.
   Google Scholar
• Said S, Sethi S, Valeri A, Leung N, Cornell L, Fidler M, Herrera Hernandez L, Vrana J, Theis J, Quint P, et al. 2013. Renal amyloidosis: Origin and clinico-pathologic correlations of 474 recent cases. Clin J Am Soc Nephrol. 8(9):1515–1523.
   PubMed Web of Science ®Google Scholar
• Satoh K, Nigro P, Zeidan A, Soe N, Jaffré F, Oikawa M, O'Dell M, Cui Z, Menon P, Lu Y, et al. 2011. Cyclophilin A promotes cardiac hypertrophy in apoE-deficient mice. Arterioscler Thromb Vasc Biol. 31:116–1123.
   Web of Science ®Google Scholar
• Seko Y, Fujimura T, Taka H, Mineki R, Murayama K, Nagai R. 2004. Hypoxia followed by reoxygenation induces secretion of cyclophilin A from cultured rat cardiac myocytes. Biochem Biophys Res Commun. 317(1):162–168.
   PubMed Web of Science ®Google Scholar
• Sherry B, Yarlett N, Strupp A, Cerami A. 1992. Identification of cyclophilin as a pro-inflammatory secretory product of LPS-activated macrophages. Proc Natl Acad Sci USA. 89(8):3511–3515.
   PubMed Web of Science ®Google Scholar
• Spik G, Haendler B, Delmas O, Mariller C, Chamoux M, Maes P, Tartar A, Montreuil J, Stedman K, Kocher H. 1991. A novel secreted cyclophilin-like protein (SCYLP). J Biol Chem. 266(17):10735–10738.
   PubMed Web of Science ®Google Scholar
• Suffredini A, Fantuzzi G, Badolato R, Oppenheim J, O'Grady N. 1999. New insights into biology of the acute phase response. J Clin Immunol. 19(4):203–214.
   PubMed Web of Science ®Google Scholar
• Till J, McCulloch E. 1961. A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. Radiat Res. 14(2):213.
   PubMed Web of Science ®Google Scholar
• Tirziu D, Moodie K, Zhuang Z, Singer K, Helisch A, Dunn J, Li W, Singh J, Simons M. 2005. Delayed arteriogenesis in hypercholesterolemic mice. Circulation. 112(16):2501–2509.
   PubMed Web of Science ®Google Scholar
• Wang P, Heitman J. 2005. The cyclophilins. Genome Biol. 6(7):226.
   PubMed Web of Science ®Google Scholar
• Westermark G, Fändrich M, Westermark P. 2015. AA amyloidosis: Pathogenesis and targeted therapy. Annu Rev Pathol. 10:321–344.
   PubMed Web of Science ®Google Scholar
• Xu Q, Leiva M, Fischkoff S, Handschumacher R, Lyttle C. 1992. Leukocyte chemotactic activity of cyclophilin. J Biol Chem. 267(17):11968–11971.
   PubMed Web of Science ®Google Scholar